| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 2 |
| 1 | ACETAMINOPHEN 500MG | 2 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 2 |
| 3 | DABRAFENIB | 2 |
| 4 | PAIN RELIEVER | 2 |
| 5 | TRAMETINIB | 2 |
| 6 | ADALIMUMAB | 1 |
| 7 | ALLOPURINOL | 1 |
| 8 | AXICABTAGENE CILOLEUCEL | 1 |
| 9 | BEVACIZUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 1 | 0.0009 |
| 1 | OXYMETAZOLINE HYDROCHLORIDE OPHTHALMIC | 1 | 0.0004 |
| 2 | TOBRAMYCIN AND DEXAMETHASONE | 1 | 0.0003 |
| 3 | RITUXIMAB-ABBS | 1 | 0.0002 |
| 4 | IOHEXOL | 1 | 0.0001 |
| 5 | AXICABTAGENE CILOLEUCEL | 1 | 0.0001 |
| 6 | DABRAFENIB | 2 | 0.0001 |
| 7 | TRAMETINIB | 2 | 0.0001 |
| 8 | LIFITEGRAST | 1 | 0.0001 |
| 9 | ERYTHROMYCIN | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 2 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| 2 | Vitamin C [EPC] | 2 |
| 3 | Alkylating Drug [EPC] | 1 |
| 4 | Aminoglycoside Antibacterial [EPC] | 1 |
| 5 | Aminosalicylate [EPC] | 1 |
| 6 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 1 |
| 8 | Calcium [EPC] | 1 |
| 9 | Corticosteroid [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 1 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |
| 2 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 3 | Radiographic Contrast Agent [EPC] | 1 | 0.0000 |
| 4 | Aminoglycoside Antibacterial [EPC] | 1 | 0.0000 |
| 5 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |
| 6 | Aminosalicylate [EPC] | 1 | 0.0000 |
| 7 | Calcium [EPC] | 1 | 0.0000 |
| 8 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 1 | 0.0000 |